U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Receptors, TNF-Related Apoptosis-Inducing Ligand

Tumor necrosis factor receptor family members that are widely expressed and play a role in regulation of peripheral immune responses and APOPTOSIS. The receptors are specific for TNF-RELATED APOPTOSIS-INDUCING LIGAND and signal via conserved DEATH DOMAINS that associate with specific TNF RECEPTOR-ASSOCIATED FACTORS in the CYTOPLASM.

Year introduced: 2007(1997)

PubMed search builder options

Subheadings:

Tree Number(s): D12.776.543.750.690.600, D12.776.543.750.705.852.760.396

MeSH Unique ID: D053220

Entry Terms:

  • Receptors, TNF Related Apoptosis Inducing Ligand
  • Receptors, Tumor Necrosis Factor, Member 10
  • Tumor Necrosis Factor Receptor Superfamily, Member 10
  • TNF-Related Apoptosis-Inducing Ligand Receptors
  • TNF Related Apoptosis Inducing Ligand Receptors
  • TRAIL Receptors
  • Receptors, TRAIL
  • Receptors, Tumor Necrosis Factor, Member 10b
  • TRAIL Receptor 2
  • Receptor, TRAIL-2
  • Receptor, TRAIL 2
  • TRAIL-2 Receptor
  • Death Receptor-5
  • Death Receptor 5
  • Tumor Necrosis Factor Receptor Superfamily, Member 10b
  • TNF-Related Apoptosis-Inducing Ligand Receptor 2
  • TNF Related Apoptosis Inducing Ligand Receptor 2
  • CD262 Antigen
  • Antigen, CD262
  • DR5 Receptor
  • Receptor, DR5
  • Receptors, Tumor Necrosis Factor, Member 10a
  • Tumor Necrosis Factor Receptor Superfamily, Member 10a
  • Death Receptor-4
  • Death Receptor 4
  • Receptor-4, Death
  • Receptor, TRAIL-1
  • Receptor, TRAIL 1
  • TRAIL-1 Receptor
  • TRAIL Receptor 1
  • DR4 Receptor
  • Receptor, DR4
  • CD261 Antigen
  • Antigen, CD261
  • APO2 Receptor
  • Receptor, APO2
  • Receptors, Tumor Necrosis Factor, Member 10d
  • Decoy Receptor 2, Tumor Necrosis Factor
  • CD264 Antigen
  • Antigen, CD264
  • TRAIL Receptor 4
  • Receptor 4, TRAIL
  • Receptor, TRAIL-4
  • Receptor, TRAIL 4
  • TRAIL-4 Receptor
  • DCR2 Receptor
  • Receptor, DCR2

Supplemental Content

Loading ...